- Report
- July 2022
- 100 Pages
Global
From €2643EUR$2,750USD£2,267GBP
- Report
- May 2023
- 450 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- January 2022
- 115 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- June 2020
- 71 Pages
Europe
From €4565EUR$4,750USD£3,915GBP
- Report
- April 2023
- 115 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- April 2023
- 120 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- April 2023
- 100 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- November 2023
- 88 Pages
Germany
From €3364EUR$3,500USD£2,885GBP
- Report
- March 2022
- 40 Pages
Saudi Arabia
From €2494EUR$2,595USD£2,139GBP
- Report
- March 2022
- 40 Pages
India
From €2494EUR$2,595USD£2,139GBP
- Report
- February 2022
- 100 Pages
Global
From €4609EUR$4,795USD£3,952GBP
- Report
- February 2022
- 40 Pages
India
From €2494EUR$2,595USD£2,139GBP
- Report
- February 2022
- 40 Pages
Saudi Arabia
From €2494EUR$2,595USD£2,139GBP
- Report
- February 2022
- 40 Pages
United States
From €2494EUR$2,595USD£2,139GBP
- Report
- April 2022
- 94 Pages
Europe
From €1442EUR$1,500USD£1,236GBP
- Report
- May 2022
- 100 Pages
Global
From €3500EUR$3,901USD£3,106GBP
- Report
- March 2022
- 40 Pages
Vietnam
From €2494EUR$2,595USD£2,139GBP
- Report
- March 2022
- 40 Pages
United States
From €2494EUR$2,595USD£2,139GBP
- Report
- March 2022
- 40 Pages
South Korea
From €2494EUR$2,595USD£2,139GBP
- Report
- March 2022
- 40 Pages
Russia
From €2494EUR$2,595USD£2,139GBP
The Cancer Genetics market is a subset of the Genomics market, focusing on the study of genetic mutations associated with cancer. This includes the identification of genetic markers that can be used to diagnose, monitor, and treat cancer. It also includes the development of targeted therapies and personalized medicine. Cancer Genetics research is conducted through a variety of methods, such as sequencing, bioinformatics, and gene expression analysis.
The Cancer Genetics market is driven by the increasing prevalence of cancer, advances in technology, and the growing demand for personalized medicine. Additionally, the increasing availability of genomic data and the development of new technologies are expected to drive the market in the future.
Some companies in the Cancer Genetics market include Illumina, Thermo Fisher Scientific, BGI, QIAGEN, and Agilent Technologies. Show Less Read more